396 related articles for article (PubMed ID: 21689707)
1. The 13-valent pneumococcal conjugate vaccine (PCV13) elicits cross-functional opsonophagocytic killing responses in humans to Streptococcus pneumoniae serotypes 6C and 7A.
Cooper D; Yu X; Sidhu M; Nahm MH; Fernsten P; Jansen KU
Vaccine; 2011 Sep; 29(41):7207-11. PubMed ID: 21689707
[TBL] [Abstract][Full Text] [Related]
2. Post hoc analysis of a randomized double-blind trial of the correlation of functional and binding antibody responses elicited by 13-valent and 7-valent pneumococcal conjugate vaccines and association with nasopharyngeal colonization.
Juergens C; Patterson S; Trammel J; Greenberg D; Givon-Lavi N; Cooper D; Gurtman A; Gruber WC; Scott DA; Dagan R
Clin Vaccine Immunol; 2014 Sep; 21(9):1277-81. PubMed ID: 24990907
[TBL] [Abstract][Full Text] [Related]
3. Comparative immunogenicity of 7 and 13-valent pneumococcal conjugate vaccines and the development of functional antibodies to cross-reactive serotypes.
Grant LR; O'Brien SE; Burbidge P; Haston M; Zancolli M; Cowell L; Johnson M; Weatherholtz RC; Reid R; Santosham M; O'Brien KL; Goldblatt D
PLoS One; 2013; 8(9):e74906. PubMed ID: 24086394
[TBL] [Abstract][Full Text] [Related]
4. Novel pneumococcal serotypes 6C and 6D: anomaly or harbinger.
McEllistrem MC; Nahm MH
Clin Infect Dis; 2012 Nov; 55(10):1379-86. PubMed ID: 22903767
[TBL] [Abstract][Full Text] [Related]
5. Immunogenicity and safety of 13-valent pneumococcal conjugate vaccine given to korean children receiving routine pediatric vaccines.
Kim DS; Shin SH; Lee HJ; Hong YJ; Lee SY; Choi KM; Oh CE; Kim KH; Juergens C; Patterson S; Giardina PC; Gruber WC; Emini EA; Scott DA
Pediatr Infect Dis J; 2013 Mar; 32(3):266-73. PubMed ID: 23011012
[TBL] [Abstract][Full Text] [Related]
6. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine.
Bryant KA; Block SL; Baker SA; Gruber WC; Scott DA;
Pediatrics; 2010 May; 125(5):866-75. PubMed ID: 20435707
[TBL] [Abstract][Full Text] [Related]
7. Comparative immunogenicity and efficacy of 13-valent and 7-valent pneumococcal conjugate vaccines in reducing nasopharyngeal colonization: a randomized double-blind trial.
Dagan R; Patterson S; Juergens C; Greenberg D; Givon-Lavi N; Porat N; Gurtman A; Gruber WC; Scott DA
Clin Infect Dis; 2013 Oct; 57(7):952-62. PubMed ID: 23804191
[TBL] [Abstract][Full Text] [Related]
8. The 15-valent pneumococcal conjugate vaccine V114 induces cross-reactive antibodies against pneumococcal serotype 6C.
Shi Y; Nolan KM; Burton RL; Shekar T; Murphy RD; Banniettis N; Musey L; Buchwald UK
Hum Vaccin Immunother; 2023 Aug; 19(2):2235238. PubMed ID: 37529944
[TBL] [Abstract][Full Text] [Related]
9. Predicted serotype-specific effectiveness of pneumococcal conjugate vaccines V114 and PCV20 against invasive pneumococcal disease in children.
Ryman J; Sachs JR; Yee KL; Banniettis N; Weaver J; Weiss T
Expert Rev Vaccines; 2024; 23(1):60-68. PubMed ID: 38073483
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the seven-valent and thirteen-valent pneumococcal conjugate vaccines in England: The indirect cohort design, 2006-2018.
Andrews N; Kent A; Amin-Chowdhury Z; Sheppard C; Fry N; Ramsay M; Ladhani SN
Vaccine; 2019 Jul; 37(32):4491-4498. PubMed ID: 31272872
[TBL] [Abstract][Full Text] [Related]
11. The 7-valent pneumococcal conjugate vaccine elicits cross-functional opsonophagocytic killing responses to Streptococcus pneumoniae serotype 6D in children.
Lee H; Cha JH; Nahm MH; Burton RL; Kim KH
BMC Infect Dis; 2013 Oct; 13():474. PubMed ID: 24112237
[TBL] [Abstract][Full Text] [Related]
12. Differential effects of pneumococcal vaccines against serotypes 6A and 6C.
Park IH; Moore MR; Treanor JJ; Pelton SI; Pilishvili T; Beall B; Shelly MA; Mahon BE; Nahm MH;
J Infect Dis; 2008 Dec; 198(12):1818-22. PubMed ID: 18983249
[TBL] [Abstract][Full Text] [Related]
13. Impact of IgM Antibodies on Cross-Protection against Pneumococcal Serogroups 6 and 19 after Immunization with 7-Valent Pneumococcal Conjugate Vaccine in Children.
Cho HK; Park IH; Burton RL; Kim KH
J Korean Med Sci; 2016 Jun; 31(6):950-6. PubMed ID: 27247505
[TBL] [Abstract][Full Text] [Related]
14. Safety and immunogenicity of a 13-valent pneumococcal conjugate vaccine compared to those of a 7-valent pneumococcal conjugate vaccine given as a three-dose series with routine vaccines in healthy infants and toddlers.
Esposito S; Tansey S; Thompson A; Razmpour A; Liang J; Jones TR; Ferrera G; Maida A; Bona G; Sabatini C; Pugni L; Emini EA; Gruber WC; Scott DA; Principi N
Clin Vaccine Immunol; 2010 Jun; 17(6):1017-26. PubMed ID: 20427630
[TBL] [Abstract][Full Text] [Related]
15. Prompt effect of replacing the 7-valent pneumococcal conjugate vaccine with the 13-valent vaccine on the epidemiology of invasive pneumococcal disease in Norway.
Steens A; Bergsaker MA; Aaberge IS; Rønning K; Vestrheim DF
Vaccine; 2013 Dec; 31(52):6232-8. PubMed ID: 24176490
[TBL] [Abstract][Full Text] [Related]
16. 13-valent pneumococcal conjugate vaccine immune sera protects against pneumococcal serotype 1, 3, and 5 bacteremia in a neonatal rat challenge model.
Fernsten P; Mason KW; Yu X; Tummolo D; Belanger KA; Tsao H; Zhu D; Cooper D; Hagen M; Jansen KU
Hum Vaccin; 2011; 7 Suppl():75-84. PubMed ID: 21266856
[TBL] [Abstract][Full Text] [Related]
17. Serotype-specific effectiveness and correlates of protection for the 13-valent pneumococcal conjugate vaccine: a postlicensure indirect cohort study.
Andrews NJ; Waight PA; Burbidge P; Pearce E; Roalfe L; Zancolli M; Slack M; Ladhani SN; Miller E; Goldblatt D
Lancet Infect Dis; 2014 Sep; 14(9):839-46. PubMed ID: 25042756
[TBL] [Abstract][Full Text] [Related]
18. Pneumococcal conjugate vaccine-elicited antibody persistence and immunogenicity and safety of 13-valent pneumococcal conjugate vaccine in children previously vaccinated with 4 doses of either 7-valent or 13-valent pneumococcal conjugate vaccine.
Quinet B; Laudat F; Gurtman A; Patterson S; Sidhu M; Gruber WC; Scott DA
Pediatr Infect Dis J; 2014 Oct; 33(10):1065-76. PubMed ID: 25093973
[TBL] [Abstract][Full Text] [Related]
19. Immune response in infants to the heptavalent pneumococcal conjugate vaccine against vaccine-related serotypes 6A and 19A.
Lee H; Nahm MH; Burton R; Kim KH
Clin Vaccine Immunol; 2009 Mar; 16(3):376-81. PubMed ID: 19144787
[TBL] [Abstract][Full Text] [Related]
20. Immune response to 13-valent pneumococcal conjugate vaccine with a reduced dosing schedule.
Rodgers GL; Esposito S; Principi N; Gutierrez-Brito M; Diez-Domingo J; Pollard AJ; Snape MD; Martinón-Torres F; Gruber WC; Patterson S; Thompson A; Gurtman A; Paradiso P; Scott DA
Vaccine; 2013 Oct; 31(42):4765-74. PubMed ID: 23965217
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
